Price $16.70 |
Market Cap
523M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
46.2
|
P/B
18.15
|
P/S
8.12
|
Dividend %
-
|
|
P/CF
73.6
|
P/FCF
77.3
|
Op. Cash Flow
7.2K
|
FCF
0.1
|
|
Op. Margin
21.20%
|
Net Margin
18.10%
|
ROE
50.50%
|
ROI
43.50%
|
|
ROA
35.60%
|
EPS Growth
10.60%
|
Current Ratio
4.3
|
Debt/Equity
0.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ImmuCell Corporation (ICCC) | $5.39 | - | - | 38.6M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.25 | - | - | 19.6M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $37.52 | - | - | 946.1M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $3.96 | - | - | 1.23B | Strong Buy |
| Kindred Biosciences Inc (KIN) | $4.47 | - | - | 155.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
